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Abstract

Despite being rare, the incidence of pregnancy-related cancer is expected to rise as
women continue to delay childbearing and give birth later in their reproductive years. In this
broad category, tumors like breast cancer, dermatological neoplasia and cervical cancer are
most common and tend to arise in women of childbearing age. All pregnant women with
clinical and cytologic suspicion of cervical cancer, except for squamous atypia or low-grade
squamous intraepithelial lesions, should undergo colposcopy, with or without biopsy, the
latter being avoided if possible due to possible complications which, although rare, may
involve preterm labor initiation.
Some studies have attempted to assimilate comparable results of USG with MRI during
the gestational period by determining the sensitivity, specificity, and accuracy of trans-rectal
ultrasound (TRUS) in comparison to magnetic resonance imaging (MRI). In order to identify
the proper way to diagnose and treat the disease, because of the complexity due to
pregnancy, a multidisciplinary team consisting of a gynecologist, medical and surgical
oncologist, and radiologist should be assembled. Both maternal and fetal wellbeing should
be taken into consideration when the medical team must choose among termination of
pregnancy, delay of maternal treatment, and iatrogenic preterm delivery. Psychological
counseling also plays an important role and due to the sensitivity of the issue, should
continue through gestation and the postpartum.
In order to develop optimal guidelines for diagnosis, treatment, and outcome issues,
large scale prospective studies are needed, but feasibility may be limited due to the scarcity
of cervical cancer cases associated with pregnancy.
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Introduction
Although rare, the incidence of pregnancy-related
cancer is expected to rise as women continue to delay
childbearing and give birth later in their reproductive
years (1). For a cancer to be categorized as pregnancyassociated neoplasia, it must be diagnosed during
pregnancy or up to 1 year after delivery. The incidence
rate for this type of cancer ranges from 17 to 38
cases/100.000 births (2-4).
Within this broad category, tumors like breast
cancer, dermatological neoplasia and cervical cancer are
most common and tend to arise in women of
childbearing age. In fact, cervical cancer is the most
frequently encountered gynecologic malignancy during
the reproductive years (5), and its incidence has been
steadily increasing over the past 2 decades (6).

woman with clinical and cytologic suspicion of cervical
cancer, except for squamous atypia or low-grade
squamous

intraepithelial

lesions,

should

undergo

colposcopy, with or without biopsy, the latter avoided
when

possible

due

to

possible

(though

rare)

complications such as preterm childbirth initiation. One
of the clinical pitfalls that may occur because of
physiological cervical changes during pregnancy such as
increased vascularity, hypertrophy and hyperplasia of the
endocervical glands, is that of a CIN-like (cervical
dysplasia) diagnosis. Progression of low-grade dysplasia
to carcinoma during pregnancy is rare (7).
A biopsy-confirmed LSIL is to be followed
throughout pregnancy by cytologic examination each
trimester and revaluated 8-12 weeks postpartum. For
HSIL

lesions,

both

cytologic

and

colposcopic

monitoring is required every 8-12 weeks, especially

Discussion


because the regression rate in the postpartum period is

Pregnancy-related cervical cancer diagnosis and very high. If diagnosed in the third trimester, fetal
treatment; Clinical symptoms
maturity is awaited, followed by delivery, and then
One major advantage is that due to the regular appropriate oncologic treatment is administered.

medical consultations associated with pregnancy, early

A revised 2009 FIGO staging is used for the

detection is more likely (5). However, on the down side, diagnosis and evaluation of cervix cancer in pregnancy.
while the pregnant woman has the same clinical  Magnetic resonance imaging (MRI)
symptoms of cervix carcinoma as the non-pregnant one,

MRI can highlight the lymph node status, tumor

some of these symptoms, such as vaginal bleeding volume, and extent of the disease, with treatment
especially after sexual intercourse, may be decisions made accordingly. In early-stage cervical
misinterpreted and misdiagnosed as pregnancy-related cancer, during the first and at the beginning of the
rather than cancer-related issues. Others like pelvic pain, second trimester, taking into consideration the
symptoms that mimic urinary and large bowel diseases, importance of lymph nodes involvement, MRI as
or sciatic-like pain can be mistaken for complications of diagnostic tool (and a potentially laparoscopic
pregnancy, leading to diagnostic delay for cancer.

lymphadenectomy as a means of treatment) provides a



useful yet conservative approach. MRI provides

Cytology

Because of these circumstances, a high index of important information for the management of cervical
suspicion is required to diagnose carcinoma cervix cancer during pregnancy, no matter which treatment is
during pregnancy, with screening programs focused on followed (8).
clinical symptoms, along with PAP smears, implemented

Gadolinium (a category C drug according to US

in order to obtain an early stage diagnosis. All pregnant Food and Drug Administration), despite having no
25
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adverse affects to the neonate and being safe throughout dose calculations based on the dose estimates for radiothe gestational period, should not be used unless pharmaceuticals (12).


absolutely necessary (9).


Ultrasound vs. MRI

Positron emission tomography (PET-CT)
The fetal radiation dose from 18F-FDG PET studies

Some studies try to assimilate comparable results of is below the dose that can determine effects of radiation
USG (ultrasonography) with MRI during the gestational exposure to the fetus (13). Nevertheless, this procedure
period by determining the sensitivity, specificity, and is more sensitive and specific than other imaging tools
accuracy

of

trans-rectal

ultrasound

(TRUS)

in and can be applied as a staging and restaging method to

comparison to magnetic resonance imaging (MRI), guide treatment.
given the superiority of the latter in detecting incomplete 

Additional imaging tools

resections after cervical conization (10). Results have

As additional imaging tools, cystoscopy and

demonstrated that TRUS is comparable to MRI in sigmoidoscopy are also safe during pregnancy, and can
detecting the modification consistent with an early-stage contribute to a differential diagnosis as well as the
cervical cancer. Other studies have also revealed that diagnosis of some of the complications due to local
both TRUS and MRI are accurate and useful in extension of cervix neoplasia.
preparation for treatment of women with early-stage 

Tumor markers

cervical cancer, with the same result as above

Some tumor markers (including CA 125 and

concerning ultrasound’s accuracy in detecting residual squamous cell carcinomaantigen SCC) can be elevated
tumors (11).

during normal pregnancy. In relation to SCC, serum

In conclusion, current evidence suggests that TRUS levels are found in between 57% and 70% of women
is appropriate for determining local invasiveness in with a primary squamous cell carcinoma of the cervix,
cervical cancer, perhaps even more so than MRI. There but also in different levels in patients with squamous cell
is no evidence that Doppler ultrasound can give reliable carcinomas of the head and neck, esophagus, lung, and
information about tumor vascularization.

adenocarcinomas of the ovary and uterus. Therefore,



SCC results must be corroborated with clinical and

Computerized tomography (CT-scan)

Sometimes the risk surrounding an improper imagistic findings to increase specificity of the
diagnosis and in-time treatment are more important than diagnosis. Because these tumor markers can exhibit
the potential risk of imaging radiation. The International fluctuation during pregnancy, their role in diagnostic and
Committee

on

Radiological

Protection

(ICRP) treatment decision factor should be used with care (14).

recommends a max 100mGy dose; below that threshold 

Treatment during pregnancy

no clinical studies have revealed an association with

Because of the case complexity due to pregnancy, a

fetal death, deformity, or other developmental problems. multidisciplinary team consisting in gynecologist,
Nevertheless, these examinations should be performed medical and surgical oncologist, and radiologist should
only when necessary and the dose should be as low as be assembled to identify the best way to diagnose and
possible.

treat the disease. Both maternal and fetal wellbeing

In order to standardize all external and internal should be taken into consideration when the medical
dosages, a new generation of models is under team has to choose between termination of pregnancy,
development using standardized software for internal delay of maternal treatment, or iatrogenic preterm
26
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delivery (15, 16). A mix of medical and personal 1A2 or with lymphatic invasion, treatment includes
decisions will be involved, and may include such factors hysterectomy with lymphadenectomy.
as: stage of the disease, lymphatic nodes status,

Stage IB1 (tumor size ≤2 cm)

histological type, gestational age, and the patient’s

Vaginal radical trachelectomy (VRT) and abdominal

choice to continue the pregnancy (17).

radical trachelectomy (ART) are similar in oncologic
Despite the scarcity of clinical studies, due to the outcomes at this stage of illness, and are now considered
low rate of pregnancy-related cancer cases, some
reliable surgical procedures. Preliminary clinical studies
guidelines can be drawn. For example, for patients with
reveal that less radical procedures (deep cone and simple
early-stage disease diagnosed during the first 2
trachelectomy) could be comparable with the results of
trimesters, with absence of nodal involvement, there is
VRT and ART (22, 23), therefore reducing the risk for
an increasing tendency toward conservatory treatment,
both mother and child. First radical trachelectomy,
taking into consideration that progression to invasive
described by Dargent and recently confirmed by Ungar
disease stage during pregnancy is very rare (18). Not so
(24, 25), provides a possible approach for fertility
long ago, these patients would have been treated by
pregnancy termination, followed by standard treatment, preservation in the non-pregnant woman.
but today, the course of action for pre-invasive disease

Stages IB1 (tumor size >2 cm and higher stages)

during pregnancy is observation. Consistent with the

Despite the similarity in oncological outcomes of

International Federation of Obstetrics and Gynecology VRT and ART, the results for this stage are less than
(FIGO), staging of the disease and proper treatment can optimal.
be differentiated.
Stage IA

Neoadjuvant chemotherapy (NACT)
NACT should be avoided during the first trimester

In early invasive adenocarcinoma (IA1 and IA2) as this is the highest risk period for interfering with fetal
because of the excellent prognosis, conservative surgery development and causing birth defects. Therefore,
may be appropriate, since parametrium involvement is thorough medical counseling and a careful choice of
low (19). Nevertheless, individualization of therapy
treatment is critical before commencing therapy (26).
based on pathology review, risk assessment, and patient
NACT is an option to keep the progression of the
preference is recommended
disease low, until fetal maturation, and should be
For stage 1A1, cervical conization is both the
followed by radical hysterectomy postpartum. Even with
diagnostic method and the elective treatment (if there are
indications that NACT can improve oncological
negative margins present), and is usually performed
outcome, only a few clinical studies support this
between 14 and 20 weeks gestation (20). The alternative
approach and it remains unclear if it offers a benefit over
is to continue the pregnancy until childbirth, with
standard oncological treatment delayed until 4-6 weeks surgery alone (27), considering that the physiological
after vaginal delivery, unless obstetric indication calls changes of pregnancy result in a decreased blood
for caesarean section. Lymphadenectomy is not concentration of chemotherapeutic agents. Alternatively,
mandatory, a fact demonstrated by a study on 560 non- postpartum cisplatin chemo-sensibilisation (after radical
pregnant women with stage IA1 and IA2 disease, with hysterectomy following cesarean and pelvic radiation)
only 1.5% positive pelvic lymph nodes (21). For stage seems to be the path in the future (28).
27
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Nevertheless, NACT for the treatment of locally chemotherapy), with major negative outcomes: fetal
invasive cervical cancer during the 2nd and 3rd trimester morbidity and mortality.
of pregnancy, partially due to the fetal protection offered 

Psychological aspects

by the placental barrier-function, appears be a good

During pregnancy, psychological resilience is

option until fetal viability is obtained and a standard elevated due to the fact that the mother is “fighting” for
oncological treatment can be implement (29). In the end, her child. After childbirth, it is often more difficult for
chemotherapy has only one major contraindication, the woman to deal with cancer diagnosis and treatment.
namely, breastfeeding.

The combination of postpartum depressed mood to

No matter which treatment path is chosen, different degrees and sleep deprivation makes these
thromboembolism prevention is critical as both cancer patients extremely vulnerable. Thus it is important to
and pregnancy are risk factors.
discuss these issues with the patient before delivery and


How and when should we deliver or terminate the continue with psychological treatment after.
pregnancy?
Counseling plays an important role and, due to the
Vaginal birth has several advantages: less blood loss
sensitivity of the issue, all options should be discussed
and fewer risks than operative delivery, shorter hospital
with both mother and spouse/partner/father. .Extensive
stays, and more importantly, faster recovery in order to
counseling regarding risks could improve both short and
begin chemotherapy. Disadvantages may include trauma
long term psychological outcomes (30).
of the lower uterine section and possible wound

Conclusions

metastasis. In contrast, if pregnancy is to be terminated,
the best timing should balance the risks and benefits for

Because of the complexity surrounding pregnancy, a

the mother and fetus. In situations involving life- multidisciplinary team that includes gynecologist,
threatening maternal disease, priority is given to medical and surgical oncologist and radiologist is
maternal health management. Nevertheless, cancer required to establish the best way to diagnose and treat
treatment during pregnancy includes risks for the fetus. the disease. Both maternal and the fetal well-being
Terminating the pregnancy earlier in order to enable should be considered when the medical team must
standard oncological

treatment

includes

risks

as choose between termination of pregnancy, delay of

pregnancy loss or preterm childbirth.
Neonatal outcome

maternal treatment, or iatrogenic preterm delivery.
Psychological counseling plays an important role and

Despite the fact that most studies have revealed good due to the sensitivity of the issue, should continue
results for the fetus on long term follow up, neonatal through gestation and the postpartum.
outcome depends upon the type of treatment and more

In order to develop optimal guidelines for the

importantly, the age of gestation when the patient diagnosis, treatment, and treatment efficacy, large
undergoes treatment.

Complications after treatment prospective studies will be required, although due to the

are: pregnancy progression arrested, low or mediocre low prevalence of cervical cancer cases associated with
Apgar score, and perinatal mortality. Nonetheless, there pregnancy, carrying out such studies will present a
is always a high risk of prematurity (especially after challenge.
28
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